A positive cervical or vaginal fetal fibronectin test at 22–24 weeks predicted more than half of the spontaneous preterm births at <28 weeks (sensitivity: 0.63). [42] The relative risk for a positive ...
Biomarker tests (PartoSure, Actim Partus and the Rapid fetal fibronectin [fFN] 10Q Cassette Kit) are intended for use with other clinical information to assess the risk of preterm birth in women with ...
A new app called QUiPP could help doctors to better identify women at risk of giving birth prematurely. The app, developed at King's College London, was tested in two studies of high-risk women being ...
The diagnostics advisory committee considered evidence on the biomarker tests (PartoSure, Actim Partus and Rapid fetal fibronectin [fFN] 10Q Cassette Kit) for diagnosing preterm labour from several ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback